Global Oligonucleotide Pool Library Market
Global Oligonucleotide Pool Library Market

Oligonucleotide Pool Library Comprehensive Study by Type (12K Different Oligo per Pools, 90K Different Oligo per Pools, Other), Application (Target Capture, CRISPR/Cas9 Designs, Gene Synthesis, Library Preparation, Other) Players and Region - Global Market Outlook to 2023

Oligonucleotide Pool Library Market Segmented into XX Submarkets. | Forecast Years: 2018- 2023  

Aug 2019 Edition 234 Pages 210 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Industry Background:
Oligonucleotide pools are a highly diverse collection of single-stranded oligonucleotides synthesized using silicon-based DNA writing technology. Oligo pools are utilized in various applications such as the generation of CRISPR guide RNA (sgRNA) libraries, peptide screens, protein screens, and high-throughput reporter assays.This growth is primarily driven by Increasing Use of Synthesized Oligos in Molecular Diagnostics and Clinical Applications and Subsequent Improvements in Oligonucleotide Synthesis.

Major Players, such as Agilent Technology (United States), Eurogentec S.A (Kaneka Corporation) (Belgium), Merck Group (Sigmaaldrich) (Germany), Illumnia Inc. (United States), LGC Biosearch Technologies (United States), Eurofins Genomics (Germany), Roche Sequencing (United States), Integrated DNA Technologies (United States), Nitto Denko Avecia Inc (United States), General Biosystems (United States), Arbor Biosciences (United States), Twist Bioscience (United States), Genscript Biotech (United States), LC Sciences (United States) and Creative Biogene (United States) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

In Febuary 2019, Thermo Fisher Scientific entered into an agreement with BioNTech (Germany). Through this agreement, BioNTech's messenger RNA (mRNA) manufacturing platform will be supported by Thermo Fisher through the supply of nucleotides, enzymes, and other critical raw materials.

Market Drivers
  • Increasing Use of Synthesized Oligos in Molecular Diagnostics and Clinical Applications
  • Subsequent Improvements in Oligonucleotide Synthesis

Market Trend

Restraints
  • Price Erosion of Synthesized Oligos
  • Lack of A Unified Set of Regulations for therapeutic Oligos

Opportunities
Increasing Government Investments and R&D Expenditure in Pharmaceutical and Biotechnology Companies and Rise in Venture Capital Investments in Developed Economies
Challenges
Large-Scale Synthesis of Oligos and Delivery of Oligonucleotide Drugs to Specific Targets

AdvanceMarketAnalytics follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization of the Report:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • 12K Different Oligo per Pools
  • 90K Different Oligo per Pools
  • Other
By Application
  • Target Capture
  • CRISPR/Cas9 Designs
  • Gene Synthesis
  • Library Preparation
  • Other
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Use of Synthesized Oligos in Molecular Diagnostics and Clinical Applications
      • 3.2.2. Subsequent Improvements in Oligonucleotide Synthesis
    • 3.3. Market Challenges
      • 3.3.1. Large-Scale Synthesis of Oligos
      • 3.3.2. Delivery of Oligonucleotide Drugs to Specific Targets
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
  • 5. Global Oligonucleotide Pool Library, by Type, Application and Region (value) (2012-2017)
    • 5.1. Introduction
  • 6. Oligonucleotide Pool Library: Manufacturers/Players Analysis
    • 6.1. Company Profile
      • 6.1.1. Agilent Technology (United States)
        • 6.1.1.1. Business Overview
        • 6.1.1.2. Products/Services Offerings
        • 6.1.1.3. Financial Analysis
        • 6.1.1.4. SWOT Analysis
      • 6.1.2. Eurogentec S.A (Kaneka Corporation) (Belgium)
        • 6.1.2.1. Business Overview
        • 6.1.2.2. Products/Services Offerings
        • 6.1.2.3. Financial Analysis
        • 6.1.2.4. SWOT Analysis
      • 6.1.3. Merck Group (Sigmaaldrich) (Germany)
        • 6.1.3.1. Business Overview
        • 6.1.3.2. Products/Services Offerings
        • 6.1.3.3. Financial Analysis
        • 6.1.3.4. SWOT Analysis
      • 6.1.4. Illumnia Inc. (United States)
        • 6.1.4.1. Business Overview
        • 6.1.4.2. Products/Services Offerings
        • 6.1.4.3. Financial Analysis
        • 6.1.4.4. SWOT Analysis
      • 6.1.5. LGC Biosearch Technologies (United States)
        • 6.1.5.1. Business Overview
        • 6.1.5.2. Products/Services Offerings
        • 6.1.5.3. Financial Analysis
        • 6.1.5.4. SWOT Analysis
      • 6.1.6. Eurofins Genomics (Germany)
        • 6.1.6.1. Business Overview
        • 6.1.6.2. Products/Services Offerings
        • 6.1.6.3. Financial Analysis
        • 6.1.6.4. SWOT Analysis
      • 6.1.7. Roche Sequencing (United States)
        • 6.1.7.1. Business Overview
        • 6.1.7.2. Products/Services Offerings
        • 6.1.7.3. Financial Analysis
        • 6.1.7.4. SWOT Analysis
      • 6.1.8. Integrated DNA Technologies (United States)
        • 6.1.8.1. Business Overview
        • 6.1.8.2. Products/Services Offerings
        • 6.1.8.3. Financial Analysis
        • 6.1.8.4. SWOT Analysis
      • 6.1.9. Nitto Denko Avecia Inc (United States)
        • 6.1.9.1. Business Overview
        • 6.1.9.2. Products/Services Offerings
        • 6.1.9.3. Financial Analysis
        • 6.1.9.4. SWOT Analysis
      • 6.1.10. General Biosystems (United States)
        • 6.1.10.1. Business Overview
        • 6.1.10.2. Products/Services Offerings
        • 6.1.10.3. Financial Analysis
        • 6.1.10.4. SWOT Analysis
      • 6.1.11. Arbor Biosciences (United States)
        • 6.1.11.1. Business Overview
        • 6.1.11.2. Products/Services Offerings
        • 6.1.11.3. Financial Analysis
        • 6.1.11.4. SWOT Analysis
      • 6.1.12. Twist Bioscience (United States)
        • 6.1.12.1. Business Overview
        • 6.1.12.2. Products/Services Offerings
        • 6.1.12.3. Financial Analysis
        • 6.1.12.4. SWOT Analysis
      • 6.1.13. Genscript Biotech (United States)
        • 6.1.13.1. Business Overview
        • 6.1.13.2. Products/Services Offerings
        • 6.1.13.3. Financial Analysis
        • 6.1.13.4. SWOT Analysis
      • 6.1.14. LC Sciences (United States)
        • 6.1.14.1. Business Overview
        • 6.1.14.2. Products/Services Offerings
        • 6.1.14.3. Financial Analysis
        • 6.1.14.4. SWOT Analysis
      • 6.1.15. Creative Biogene (United States)
        • 6.1.15.1. Business Overview
        • 6.1.15.2. Products/Services Offerings
        • 6.1.15.3. Financial Analysis
        • 6.1.15.4. SWOT Analysis
  • 7. Global Oligonucleotide Pool Library Sale, by Type, Application and Region (value) (2018-2023)
    • 7.1. Introduction
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Company Basic Information, Sales Area and Its Competitors
  • Table 2. Company Basic Information, Sales Area and Its Competitors
  • Table 3. Company Basic Information, Sales Area and Its Competitors
  • Table 4. Company Basic Information, Sales Area and Its Competitors
  • Table 5. Company Basic Information, Sales Area and Its Competitors
  • Table 6. Company Basic Information, Sales Area and Its Competitors
  • Table 7. Company Basic Information, Sales Area and Its Competitors
  • Table 8. Company Basic Information, Sales Area and Its Competitors
  • Table 9. Company Basic Information, Sales Area and Its Competitors
  • Table 10. Company Basic Information, Sales Area and Its Competitors
  • Table 11. Company Basic Information, Sales Area and Its Competitors
  • Table 12. Company Basic Information, Sales Area and Its Competitors
  • Table 13. Company Basic Information, Sales Area and Its Competitors
  • Table 14. Company Basic Information, Sales Area and Its Competitors
  • Table 15. Company Basic Information, Sales Area and Its Competitors
  • Table 16. Research Programs/Design for This Report
  • Table 17. Key Data Information from Secondary Sources
  • Table 18. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Agilent Technology (United States) Revenue, Net Income and Gross profit
  • Figure 5. Agilent Technology (United States) Revenue: by Geography 2017
  • Figure 6. Eurogentec S.A (Kaneka Corporation) (Belgium) Revenue, Net Income and Gross profit
  • Figure 7. Eurogentec S.A (Kaneka Corporation) (Belgium) Revenue: by Geography 2017
  • Figure 8. Merck Group (Sigmaaldrich) (Germany) Revenue, Net Income and Gross profit
  • Figure 9. Merck Group (Sigmaaldrich) (Germany) Revenue: by Geography 2017
  • Figure 10. Illumnia Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 11. Illumnia Inc. (United States) Revenue: by Geography 2017
  • Figure 12. LGC Biosearch Technologies (United States) Revenue, Net Income and Gross profit
  • Figure 13. LGC Biosearch Technologies (United States) Revenue: by Geography 2017
  • Figure 14. Eurofins Genomics (Germany) Revenue, Net Income and Gross profit
  • Figure 15. Eurofins Genomics (Germany) Revenue: by Geography 2017
  • Figure 16. Roche Sequencing (United States) Revenue, Net Income and Gross profit
  • Figure 17. Roche Sequencing (United States) Revenue: by Geography 2017
  • Figure 18. Integrated DNA Technologies (United States) Revenue, Net Income and Gross profit
  • Figure 19. Integrated DNA Technologies (United States) Revenue: by Geography 2017
  • Figure 20. Nitto Denko Avecia Inc (United States) Revenue, Net Income and Gross profit
  • Figure 21. Nitto Denko Avecia Inc (United States) Revenue: by Geography 2017
  • Figure 22. General Biosystems (United States) Revenue, Net Income and Gross profit
  • Figure 23. General Biosystems (United States) Revenue: by Geography 2017
  • Figure 24. Arbor Biosciences (United States) Revenue, Net Income and Gross profit
  • Figure 25. Arbor Biosciences (United States) Revenue: by Geography 2017
  • Figure 26. Twist Bioscience (United States) Revenue, Net Income and Gross profit
  • Figure 27. Twist Bioscience (United States) Revenue: by Geography 2017
  • Figure 28. Genscript Biotech (United States) Revenue, Net Income and Gross profit
  • Figure 29. Genscript Biotech (United States) Revenue: by Geography 2017
  • Figure 30. LC Sciences (United States) Revenue, Net Income and Gross profit
  • Figure 31. LC Sciences (United States) Revenue: by Geography 2017
  • Figure 32. Creative Biogene (United States) Revenue, Net Income and Gross profit
  • Figure 33. Creative Biogene (United States) Revenue: by Geography 2017
Some of the key companies/manufacturers profiled in the report
  • Agilent Technology (United States)
  • Eurogentec S.A (Kaneka Corporation) (Belgium)
  • Merck Group (Sigmaaldrich) (Germany)
  • Illumnia Inc. (United States)
  • LGC Biosearch Technologies (United States)
  • Eurofins Genomics (Germany)
  • Roche Sequencing (United States)
  • Integrated DNA Technologies (United States)
  • Nitto Denko Avecia Inc (United States)
  • General Biosystems (United States)
  • Arbor Biosciences (United States)
  • Twist Bioscience (United States)
  • Genscript Biotech (United States)
  • LC Sciences (United States)
  • Creative Biogene (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation